Health ❯ Healthcare ❯ Patient Care

Chronic Conditions

Obesity Heart Disease Diabetes Management Obesity Management Diabetes Type 2 Diabetes Hypertension Migraine Management Asthma Management Hypertension Management

3 ARTICLES

3h ago

FDA Approves Lipfendra, First Oral PCSK9 Pill to Lower LDL Cholesterol

The once‑daily tablet offers an alternative to injectable PCSK9 drugs, with price, insurer coverage and ongoing outcomes data set to determine how widely it is used.

Stories older than 24h

31 ARTICLES

yesterday

FDA Approves First Oral PCSK9 Pill, Merck’s Lipfendra

3 ARTICLES

2d ago

Study: GLP‑1 Use Soared and Shifted Costs From Patients to Insurers and Taxpayers

3 ARTICLES

last wk.

UNAM Unveils Biodegradable Microneedle Patch for High Blood Pressure

Chronic Conditions

FDA Approves Lipfendra, First Oral PCSK9 Pill to Lower LDL Cholesterol

FDA Approves First Oral PCSK9 Pill, Merck’s Lipfendra

Study: GLP‑1 Use Soared and Shifted Costs From Patients to Insurers and Taxpayers

Ipsen Says Dysport Met Phase 3 Endpoints for Episodic and Chronic Migraine

Oxford Tool Predicts Individual Risk of Serious Statin-Related Muscle Disorders

Missing Hamburg Man With Dementia Found and Returned to Supervised Care

Experimental Antibody Preserves Muscle During Tirzepatide Weight Loss

FDA Expands Hympavzi Approval to Patients Aged 6 and Older With Hemophilia

Trial Finds Dexcom G7 Improves Glycemic Control in Non‑Insulin Type 2 Diabetes

Cervical Spinal Stimulation Restores Arm Strength in Small Stroke Trial

Never miss stories about

Chronic Conditions

Brazil Approves 24‑Hour Subcutaneous Levodopa Therapy for Advanced Parkinson

EMA Recommends Jascayd for Two Progressive Lung Fibrosis Conditions

Katie Price Tells GMB Her Mother Is ‘Really Not Well’ After Solo Appearance

NHLBI-Backed JAMA Study Finds MRI and Blood Tests Improve HCM Risk Prediction

Michigan Medicine–Blue Cross Talks Drag On With July 1 Coverage Split Threat

LivaNova Reports 11% Q1 Growth as FDA PMA and New Data Propel Sleep Apnea Push

England Marks Major Shift Away From Blue Asthma Inhalers

World Asthma Day Highlights Fixable Asthma Control Gap in Argentina

Anvisa Approves Mounjaro for Type 2 Diabetes in Children Ages 10–17

UNAM Unveils Biodegradable Microneedle Patch for High Blood Pressure

Never miss stories about

Chronic Conditions